Canopus Biopharma's total assets for Q2 2023 were $6.15K, an increase of 93.80% from the previous quarter. CBIA total liabilities were $191.11K for the fiscal quarter, a 984.55% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
